SCHEMBL1567073

SCHEMBL1567073

CCOC(=O)C(C(CC(=O)c1ccccc1)c1ccc(OC)cc1)[N+](=O)[O-]

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.56
NPC1 O15118 6/20 0.51
ALDH1A1 P00352 5/20 0.51
RAB9A P51151 4/20 0.51
MAPT P10636 3/20 0.51
SMN1; SMN2 Q16637 2/20 0.51
LMNA P02545 2/20 0.51
KMT2A Q03164 3/20 0.50
MEN1 O00255 2/20 0.50
TDP1 Q9NUW8 1/20 0.49
GAA P10253 2/20 0.45
MGAM O43451 1/20 0.45
SI P14410 1/20 0.45
MGAM2 Q2M2H8 1/20 0.45
NPSR1 Q6W5P4 2/20 0.41
PAX8 Q06710 1/20 0.41
HDAC3 O15379 1/20 0.41
HDAC4 P56524 1/20 0.41
HDAC1 Q13547 1/20 0.41
HDAC7 Q8WUI4 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18551876 0.91 KMT2A (0.57) L3MBTL1NPC1ALDH1A1MAPTSMN1; SMN2
SCHEMBL12971324 0.88 NPC1 (0.52) L3MBTL1NPC1ALDH1A1RAB9AMAPT
SCHEMBL657566 0.86 ALDH1A1 (0.46) L3MBTL1NPC1ALDH1A1RAB9AMAPT
SCHEMBL18551753 0.86 ALDH1A1 (0.41) L3MBTL1NPC1ALDH1A1RAB9AMAPT
SCHEMBL18551794 0.83 ALDH1A1 (0.45) L3MBTL1NPC1ALDH1A1MAPTSMN1; SMN2
SCHEMBL9872402 0.81 GAA (0.49) NPC1ALDH1A1MAPTLMNAKMT2A
SCHEMBL18551820 0.81 KMT2A (0.43) L3MBTL1NPC1ALDH1A1LMNAKMT2A
SCHEMBL16669979 0.79 ALDH1A1 (0.46) NPC1ALDH1A1RAB9AMAPTSMN1; SMN2
SCHEMBL10253421 0.79 NPC1 (0.41) NPC1ALDH1A1RAB9AMAPTSMN1; SMN2
SCHEMBL7404983 0.79 ALOX15 (0.43) L3MBTL1ALDH1A1MAPTLMNAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2483242-B1 New histone deacetylase inhibitors based simultaneously on trisubstituted 1h-pyrroles and aromatic and heteroaromatic spacers IKERCHEM S L (ES) 2013-12-11 EP disclosed
EP-2483242-A1 NEW HISTONE DEACETYLASE INHIBITORS BASED SIMULTANEOUSLY ON TRISUBSTITUTED 1H-PYRROLES AND AROMATIC AND HETEROAROMATIC SPACERS Ikerchem, S.L. (ES) 2012-08-08 EP disclosed
US-20120196885-A1 NEW HISTONE DEACETYLASE INHIBITORS BASED SIMULTANEOUSLY ON TRISUBSTITUTED 1H-PYRROLES AND AROMATIC AND HETEROAROMATIC SPACERS IKERCHEM, S.L. (ES) 2012-08-02 US disclosed
WO-2011039353-A1 NEW HISTONE DEACETYLASE INHIBITORS BASED SIMULTANEOUSLY ON TRISUBSTITUTED 1H-PYRROLES AND AROMATIC AND HETEROAROMATIC SPACERS IKERCHEM, S.L. (ES) 2011-04-07 WO disclosed
EP-2305643-A1 New histone deacetylase inhibitors based simultaneously on trisubstituted 1h-pyrroles and aromatic and heteroaromatic spacers Ikerchem, S.L. (ES) 2011-04-06 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120196885-A1 NEW HISTONE DEACETYLASE INHIBITORS BASED SIMULTANEOUSLY ON TRISUBSTITUTED 1H-PYRROLES AND AROMATIC AND HETEROAROMATIC SPACERS HDAC1, HDAC3, HDAC11 L3MBTL1 1302/4885NPC1 4362/4885ALDH1A1 571/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.